Clinical Trial Update: Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin [Phase 3]

View source ↗

Summary

Phase 3 trial update on the efficacy and safety of lixisenatide added to metformin in patients with Type 2 Diabetes Mellitus inadequately controlled by metformi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lixisenatide (lixisenatide)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2016-10-13